Therapeutic vaccines for NSCLC: From mechanisms to clinical translation
Weijing Liu, Jiefei Han, Kailun Fei, Yiting Dong, Man Li, Jie Zhao, Mingzhao Wang, Zhuoran Li, Siyuan Chen, Jiachen Xu, Amit Jain · 2026
Read Therapeutic vaccines for NSCLC: From mechanisms to clinical translation by Weijing Liu, Jiefei Han, Kailun Fei, Yiting Dong, Man Li, Jie Zhao, Mingzhao Wang, Zhuoran Li, Siyuan Chen, Jiachen Xu, Amit Jain (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13649483.txt.
Description
Liu and co-authors review treatment vaccines for the most common form of lung cancer. Unlike preventive shots, these vaccines treat cancer that is already present. They train the patient's own killer cells to hunt the tumor and to remember it.
Lasting control of this cancer stays rare, even with newer targeted and immune drugs. Vaccine gains so far have been uneven. In advanced disease, fast growth, faulty display of tumor marks, and a hostile tumor setting blunt the vaccine's cells. The authors argue the best window may be when tumor bulk is low and display systems still work. They map the vaccine designs now in trials. Their review sets out what must line up for the approach to succeed.
Catalog record
| CREATOR | Weijing Liu, Jiefei Han, Kailun Fei, Yiting Dong, Man Li, Jie Zhao, Mingzhao Wang, Zhuoran Li, Siyuan Chen, Jiachen Xu, Amit Jain |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 121 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |